• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Allergy-Care
    / Trima

    Active Ingredient
    Cetirizine (dihydrochloride) 10 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    20 X 10 mg

    partial basket chart 70126 1418

    Related information


    Children aged 6-12: half a tablet, twice a day, in the morning and evening, or one tablet once a day.
    Children weighing less than 30 kg: half a tablet, once a day.
    Adults and children from 12 years of age: one tablet per day, at most.
    See package insert (OTC).


    Antihistaminic drug for the treatment of allergies. For the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 2 years and over and adults.


    Kidney or urinary tract dysfunction, heart rate disturbance. Known hypersensitivity, newborn or premature babies, lactation, asthma or other lower respiratory tract conditions, narrow-angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, pyloroduodenal obstruction, concomitant use with monoamine oxidase inhibitor therapy.

    Special Precautions

    Safety of use in pregnancy has not been established. The drug should therefore be used during pregnancy only if clearly needed. Drowsiness, history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, hypertension.

    Side Effects

    Drowsiness, lassitude, giddiness, epigastric distress, dryness of mouth, blurred vision, cardiac palpitations, flushing, increased irritability or excitement (especially in children).

    Drug interactions

    Alcohol, CNS depressants, anticholinergics.

    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel